Sandbox:Preeti: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "__NOTOC__ {{CMG}}; {{AE}} {{Preeti}} ==References== {{Reflist|2}} {{WH}} {{WS}} Category: (name of the system)")
Tag: Replaced
 
(55 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{Preeti}}
{{CMG}}; {{AE}} {{Preeti}}


{| class="wikitable"
! colspan="3" rowspan="2" |
! rowspan="2" |Pathophysiology
! rowspan="2" |Symptoms
! rowspan="2" |History
! rowspan="2" |Physical  Examination
! colspan="3" |Laboratory Findings
|-
!Immunochemistry
!Blood work
!Biospy/CT/CXR
|-
| rowspan="9" |'''Infections'''
| rowspan="3" |'''Bacterial'''
| rowspan="2" |'''Syphilis'''
| rowspan="2" |
* Syphilis is caused by a [[spirochete]], [[Treponema pallidum|''Treponema pallidum'']].


* It has an average incubation period of 3 - 12 weeks.
==References==
* Spirochete penetrates intact mucous membrane or microscopic dermal abrasions and rapidly enters systemic circulation with the [[central nervous system]] being invaded during the early phase of infection.
{{Reflist|2}}
* The histopathological hallmark findings are endarteritis and plasma cell-rich infiltrates reflecting a delayed-type of hypersensitivity reaction to the spirochete.
| rowspan="2" |
'''Primary syphilis'''
* Mononuclear leukocytic infiltration, [[macrophages]], and [[lymphocytes]]
* Swelling and proliferation of small blood vessels
'''Secondary syphilis'''
* Swelling and dilatation of blood vessels in the [[dermis]]
* Epidermal [[hyperplasia]] and neutrophilic infiltration
* Inflammatory cell infiltrate, predominantly [[plasma cell]]
'''Tertiary syphilis'''
* Small vessel inflammation ([[endarteritis obliterans]])
* Granulomatous lesions ([[gumma]]) containing central necrosis, inflammatory cells, such as [[lymphocytes]], [[macrophages]], [[plasma cells]] and [[Fibroblast|fibroblasts]].
| rowspan="2" |
| rowspan="2" |
| rowspan="2" |
*


* A presumptive diagnosis of syphilis is possible with the use of two types of serologic tests.
{{WH}}
:* Nontreponemal tests (e.g., [[VDRL|venereal disease research laboratory (VDRL)]] and [[RPR|rapid plasma reagent test]]) and
{{WS}}
:* Treponemal tests (e.g., [[FTA-ABS|fluorescent treponemal antibody absorbed (FTA-ABS) tests]], the ''T. pallidum'' passive particle agglutination (TP-PA) assay, various [[Enzyme linked immunosorbent assay (ELISA)|enzyme immunoassays]], and [[Chemiluminescence|chemiluminescence immunoassays]]).
[[Category: (name of the system)]]
|
| rowspan="2" |Darkfield examinations and tests to detect ''[[T. pallidum]].''
|-
|
|-
|'''Brucellosis'''
|[[humans]] could be infected by eating undercook meat or raw [[Dairy product|dairy]] products, inhalation of the [[bacteria]] and direct contact of bacteria with [[skin]] [[wounds]] or [[Mucous membranes|mucous membranes.]] Following transmission, [[white blood cells]] phagocyte the pathogen and transports it via hematologic or [[Lymphatic system|lymphatic route]] to different organs specially to those of the [[reticuloendothelial system]].
|
* Fever
* Rash
* Abdominal pain
* weightloss
* Painful lymphadenopathy
* hepatosplenomegaly
* arthritis
|
 
|
|
* [[Lymphocytosis|Relative lymphocytosis]]
* positive titer of anti-[[Brucella|b''rucella'']] [[antibodies]] on serological testing
* There are two types of serological tests, based on:
** Antibody production against [[lipopolysaccharide]]
** Antibody production against other [[bacterial]] [[antigens]]
|
|
* [[Brucella|''Brucella'']] is most commonly isolated from blood cultures (blood cultures are positive between the 7th and 21st day)
|-
| rowspan="4" |'''Viral'''
|'''infectious mononucleosis'''
|
|
|
|
|
|
|
|-
|'''cytomegalovirus'''
|
|
|
|
|
|
|
|-
|'''human immunodeficiency virus'''
|
|
|
|
|
|
|
|-
|'''cat scratch fever'''
|
|
|
|
|
|
|
|-
|'''Mycobacterial'''
|'''tuberculosis'''
|
* Mostly in endemic areas
|Symptoms include [[productive cough]],[[night sweats]], [[fever]] and [[weight loss]]
|
|
|
* [[Sputum]] smear positive for [[acid-fast bacilli]]<nowiki/>and nucleic acid amplification tests (NAAT) is used on sputum or any sterile fluid for rapid diagnosis and is positive for mycobacteria.
|
|
* CXR and CT demonstrates [[Internal|cavities]] in the upper lobe of the lung
|-
|'''Parasitic'''
|'''toxoplasmosis'''
|
|
|
|
|
|
|
|-
| rowspan="4" |'''Autoimmune'''
| colspan="2" |'''Systemic lupus erythematosus'''
|
|
|
|
|
|
|
|-
| colspan="2" |'''Sjögren's syndrome'''
|
|
|
|
|
|
|
|-
| colspan="2" |'''Hydantoin derivatives'''
|
|
|
|
|
|
|
|-
| colspan="2" |'''Sarcoidosis'''
|
* More common in African-American females
* Often [[asymptomatic]] except for [[Lymphadenopathy|enlarged lymph nodes]]
* Associated with [[restrictive lung disease]]
* [[Erythema nodosum]]
* [[Lupus pernio]] (skin lesions on face resembling lupus)
* [[Bell's palsy|Bell palsy]]
* [[Epithelioid]] [[granuloma]]<nowiki/>s containing microscopic [[Schaumann bodies|Schaumann]] and asteroid bodies
|
|
|
|
|
|
* On CXR bilateral [[Lymphadenopathy|adenopathy]] and coarse reticular opacities are seen.
* CT of the chest demonstrates extensive [[Hilar lymphadenopathy|hilar]] and mediastinal adenopathy
* Additional findings on CT include [[fibrosis]] (honeycomb, linear, or associated with bronchial distortion), pleural thickening, and ground-glass opacities.
* Biopsy of lung shows non-[[caseating]][[granuloma]]
|-
| rowspan="6" |'''Neoplasms'''
| colspan="2" rowspan="1" |'''Hodgkin's disease'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Chronic lymphocytic leukemia'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Small cell carcinoma of the lung'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Malignant histiocytosis'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Melanoma'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Germ cell neoplasms'''
|
|
|
|
|
|
|
|-
| rowspan="5" |'''Other conditions'''
| colspan="2" rowspan="1" |'''Reactive lymphoid hyperplasia'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Lymphomatoid granulomatosis'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Dermatopathic lymphadenopathy'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Angioimmunoblastic lymphadenopathy'''
|
|
|
|
|
|
|
|-
| colspan="2" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)'''
|
|
|
|
|
|
|
|}

Latest revision as of 16:32, 8 March 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]


References

Template:WH Template:WS